RBCC Works to Take Biotech Out of the Lab and Into the Marketplace
NOKOMIS, Fla.–Joining forces with Nano3D Biosciences is the first step in Rainbow Coral Corp.’s (OTCBB:RBCC) plans to take biotechnology out of the laboratory and into the marketplace.
“It’s our goal to help create a new business model to widely distribute the Bio-Assembler system into the health and research marketplace,” said RBCC CEO Patrick Brown. “This is a revolutionary cell culturing system that will dramatically shorten the development pipeline for cellular research into cures for chronic illnesses and debilitating injuries.”
The Bio-Assembler is a proprietary system developed by Nano3D Biosciences, Inc. (n3D) in collaboration with the MD Anderson Cancer Center and Rice University in Houston. The Bio-Assembler enables scientists to grow and study cells in a three-dimensional environment more easily than ever before. Rainbow BioSciences, RBCC’s new biotech division, is forging ahead with due diligence to acquire or form a new joint venture with the cutting-edge biotech firm.
The global market for bioscience innovations is booming. Companies in the biotech sector alone pulled in $25 billion in capital last year, a 15-percent jump from the previous record in 2007.
“We feel the sky is the limit for our future initiatives because we’re helping to transition leading-edge research into practical, affordable treatments for people who need them,” Brown said.
For more information on Rainbow BioSciences, RBCC’s biotechnology division, please visit www.rainbowbiosciences.com/investors.
Rainbow BioSciences will develop new medical and research technology innovations to compete alongside companies such as Cell Therapeutics, Inc. (NASDAQ: CTIC), Abbott Laboratories (NYSE: ABT) Affymax, Inc. (NASDAQ: AFFY), and Celgene Corp. (NASDAQ: CELG).
About Rainbow BioSciences
Rainbow BioSciences is a division of Rainbow Coral Corp. (OTCBB: RBCC). The company continually seeks out new partnerships with biotechnology developers to deliver profitable new medical technologies and innovations. For more information on our growth-oriented business initiatives, please visit our website at [www.rainbowbiosciences.com]. For investment information and performance data on the company, please visit www.RainbowBioSciences.com/investors.

